Current treatment options for secondary hyperparathyroidism in patients with stage 3 to 4 chronic kidney disease and vitamin D deficiencyAndrea Galassi, Mario Cozzolino, Paola Ciceri et al.|Expert Opinion on Drug Safety|2021Cited by 10